Data Without Interpretation is Meaningless: Unlocking Inherent Value Within the Numbers

Episode 18 • February 25, 2025 • 00:23:33
Data Without Interpretation is Meaningless: Unlocking Inherent Value Within the Numbers
LifeSci Talks
Data Without Interpretation is Meaningless: Unlocking Inherent Value Within the Numbers

Feb 25 2025 | 00:23:33

/

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Elizabeth (Nicki) Bush, Executive Director and Global Head of Endpoint Strategy and COA Measurement at OPEN Health Group to discuss the growing complexity of collecting and interpreting patient data. With insights from the recent FDA workshop around Patient-Focused Drug Development (PFFD), the two discuss the importance of integrating measurement science early in the study design, improving data quality while minimizing patient burden, and ensuring patient data is not just gathered, but meaningfully applied in regulatory submissions.

Other Episodes

Episode 11

June 09, 2026 • 00:22:51
Episode Cover

The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant...

Listen

Episode 9

December 18, 2023 • 00:24:08
Episode Cover

Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity with Craig Lipset

DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host...

Listen

Episode 20

July 01, 2025 • 00:23:33
Episode Cover

Balancing Innovation and Integrity: AI’s Place in Patient-Focused Research

Artificial intelligence is redefining what’s possible across the clinical development lifecycle, but with rapid innovation comes the need for thoughtful oversight. In this episode...

Listen